Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma.

Cancers (Basel) · 2022 · PMC9559492 · PMID 36230472

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

NV651 alone presented an increasing trend in the percentage of crosslinks with time, with some variability between cell lines ( Figure 5 C,D). 3.6.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.